메뉴 건너뛰기




Volumn 67, Issue 3, 2010, Pages 217-222

Bioavailability in healthy adults of efavirenz capsule contents mixed with a small amount of food

Author keywords

Antiretroviral agents; Blood levels; Drug interactions; Drugs, availability; Efavirenz; Equivalency; Food; Half life; Pharmacokinetics; Taste; Toxicity

Indexed keywords

EFAVIRENZ; YOGHURT; BENZOXAZINE DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

EID: 77449090634     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp090327     Document Type: Article
Times cited : (15)

References (6)
  • 2
    • 78650211230 scopus 로고    scopus 로고
    • Uxbridge, United Kingdom: Bristol-Myers Squibb Pharmaceuticals Ltd.; Aug.
    • Sustiva (efavirenz) summary of product characteristics. Uxbridge, United Kingdom: Bristol-Myers Squibb Pharmaceuticals Ltd.; 2008 Aug.
    • (2008) Sustiva (Efavirenz) Summary of Product Characteristics
  • 3
    • 33846316714 scopus 로고    scopus 로고
    • Paediatric and geriatric drug delivery
    • DOI 10.1517/17425247.4.1.37
    • Breitkreutz J, Boos J. Paediatric and geriatric drug delivery. Expert Opin Drug Deliv. 2007; 4:37-45. (Pubitemid 46117485)
    • (2007) Expert Opinion on Drug Delivery , vol.4 , Issue.1 , pp. 37-45
    • Breitkreutz, J.1    Boos, J.2
  • 4
    • 78650226108 scopus 로고    scopus 로고
    • Quantitative determination of BMS-561525 (efavirenz) and BMY-40900 (didanosine) in human heparinized plasma by LC/MS/MS. BMS Saint-Nazaire, France
    • Bristol-Myers Squibb Research and Development
    • Burzawa S. Quantitative determination of BMS-561525 (efavirenz) and BMY-40900 (didanosine) in human heparinized plasma by LC/MS/MS. BMS Saint-Nazaire, France. Bristol-Myers Squibb Research and Development, BMS document control no. 930012422; 2005.
    • (2005) BMS Document Control No. 930012422
    • Burzawa, S.1
  • 6
    • 34748832865 scopus 로고    scopus 로고
    • Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen
    • for the Efavirenz/Emtricitabine/ Tenofovir Disoproxil Fumarate Single-Tablet Regimen Development Team
    • Mathias AA, Hinkle J, Menning M et al., for the Efavirenz/Emtricitabine/ Tenofovir Disoproxil Fumarate Single-Tablet Regimen Development Team. Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen. J Acquir Immune Defic Syndr. 2007; 46:167-73.
    • (2007) J Acquir Immune Defic Syndr , vol.46 , pp. 167-173
    • Mathias, A.A.1    Hinkle, J.2    Menning, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.